PMID- 26281716 OWN - NLM STAT- MEDLINE DCOM- 20161230 LR - 20220129 IS - 1873-2402 (Electronic) IS - 0006-3223 (Print) IS - 0006-3223 (Linking) VI - 79 IP - 9 DP - 2016 May 1 TI - Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia. PG - 716-726 LID - S0006-3223(15)00577-6 [pii] LID - 10.1016/j.biopsych.2015.07.005 [doi] AB - N-methyl-D-aspartate receptor (NMDAR) hypofunction in parvalbumin-expressing (PV+) inhibitory neurons (INs) may contribute to symptoms in patients with schizophrenia (SZ). This hypothesis was inspired by studies in humans involving NMDAR antagonists that trigger SZ symptoms. Animal models of SZ using neuropharmacology and genetic knockouts have successfully replicated some of the key observations in human subjects involving alteration of gamma band oscillations (GBO) observed in electroencephalography and magnetoencephalography signals. However, it remains to be seen if NMDAR hypofunction in PV+ neurons is fundamental to the phenotype observed in these models. In this review, we discuss some of the key computational models of GBO and their predictions in the context of NMDAR hypofunction in INs. While PV+ INs have been the main focus of SZ studies in animal models, we also discuss the implications of NMDAR hypofunction in other types of INs using computational models for GBO modulation in the visual cortex. CI - Copyright (c) 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved. FAU - Jadi, Monika P AU - Jadi MP AD - Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, California; Division of Biological Sciences, University of California at San Diego, La Jolla, California. Electronic address: jadi@salk.edu. FAU - Behrens, M Margarita AU - Behrens MM AD - Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, California. FAU - Sejnowski, Terrence J AU - Sejnowski TJ AD - Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, California; Division of Biological Sciences, University of California at San Diego, La Jolla, California. LA - eng GR - K99 EY025026/EY/NEI NIH HHS/United States GR - MH091407/MH/NIMH NIH HHS/United States GR - R01 MH091407/MH/NIMH NIH HHS/United States GR - T32 MH020002/MH/NIMH NIH HHS/United States GR - R01 MH094670/MH/NIMH NIH HHS/United States GR - T32MH020002/MH/NIMH NIH HHS/United States GR - MH094670/MH/NIMH NIH HHS/United States GR - HHMI_/Howard Hughes Medical Institute/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20150717 PL - United States TA - Biol Psychiatry JT - Biological psychiatry JID - 0213264 RN - 0 (Parvalbumins) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 56-12-2 (gamma-Aminobutyric Acid) SB - IM MH - Action Potentials MH - Animals MH - Cerebral Cortex/*physiopathology MH - Electroencephalography MH - GABAergic Neurons/metabolism/physiology MH - *Gamma Rhythm MH - Humans MH - Interneurons/metabolism/*physiology MH - *Models, Neurological MH - Parvalbumins/metabolism MH - Receptors, N-Methyl-D-Aspartate/genetics/*physiology MH - Schizophrenia/*physiopathology MH - gamma-Aminobutyric Acid/physiology PMC - PMC4720598 MID - NIHMS716171 OTO - NOTNLM OT - Computational models OT - Gamma oscillations OT - Inhibition OT - NMDA hypofunction OT - Parvalbumin OT - Schizophrenia EDAT- 2015/08/19 06:00 MHDA- 2016/12/31 06:00 PMCR- 2017/05/01 CRDT- 2015/08/19 06:00 PHST- 2014/12/10 00:00 [received] PHST- 2015/06/03 00:00 [revised] PHST- 2015/07/07 00:00 [accepted] PHST- 2015/08/19 06:00 [entrez] PHST- 2015/08/19 06:00 [pubmed] PHST- 2016/12/31 06:00 [medline] PHST- 2017/05/01 00:00 [pmc-release] AID - S0006-3223(15)00577-6 [pii] AID - 10.1016/j.biopsych.2015.07.005 [doi] PST - ppublish SO - Biol Psychiatry. 2016 May 1;79(9):716-726. doi: 10.1016/j.biopsych.2015.07.005. Epub 2015 Jul 17.